BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28893536)

  • 1. CREPT regulated by miR-138 promotes breast cancer progression.
    Liang Z; Feng Q; Xu L; Li S; Zhou L
    Biochem Biophys Res Commun; 2017 Nov; 493(1):263-269. PubMed ID: 28893536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-449b-5p suppresses the growth and invasion of breast cancer cells via inhibiting CREPT-mediated Wnt/β-catenin signaling.
    Jiang J; Yang X; He X; Ma W; Wang J; Zhou Q; Li M; Yu S
    Chem Biol Interact; 2019 Apr; 302():74-82. PubMed ID: 30738779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-383 acts as a tumor suppressor in colorectal cancer by modulating CREPT/RPRD1B expression.
    Li J; Smith AR; Marquez RT; Li J; Li K; Lan L; Wu X; Zhao L; Ren F; Wang Y; Wang Y; Jia B; Xu L; Chang Z
    Mol Carcinog; 2018 Oct; 57(10):1408-1420. PubMed ID: 29938829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-501-3p restricts prostate cancer growth through regulating cell cycle-related and expression-elevated protein in tumor/cyclin D1 signaling.
    Zhang Z; Shao L; Wang Y; Luo X
    Biochem Biophys Res Commun; 2019 Feb; 509(3):746-752. PubMed ID: 30621914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CREPT promotes glioma cell proliferation and invasion by activating Wnt/β-catenin pathway and is a novel target of microRNA-596.
    Wei M; Cao Y; Jia D; Zhao H; Zhang L
    Biochimie; 2019 Jul; 162():116-124. PubMed ID: 30995540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-665 expression predicts poor survival and promotes tumor metastasis by targeting NR4A3 in breast cancer.
    Zhao XG; Hu JY; Tang J; Yi W; Zhang MY; Deng R; Mai SJ; Weng NQ; Wang RQ; Liu J; Zhang HZ; He JH; Wang HY
    Cell Death Dis; 2019 Jun; 10(7):479. PubMed ID: 31209222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CREPT/RPRD1B associates with Aurora B to regulate Cyclin B1 expression for accelerating the G2/M transition in gastric cancer.
    Ding L; Yang L; He Y; Zhu B; Ren F; Fan X; Wang Y; Li M; Li J; Kuang Y; Liu S; Zhai W; Ma D; Ju Y; Liu Q; Jia B; Sheng J; Chang Z
    Cell Death Dis; 2018 Dec; 9(12):1172. PubMed ID: 30518842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer.
    Ma Z; Li Y; Xu J; Ren Q; Yao J; Tian X
    IUBMB Life; 2016 May; 68(5):394-402. PubMed ID: 27079864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer-derived exosomes regulate cell invasion and metastasis in breast cancer via miR-146a to activate cancer associated fibroblasts in tumor microenvironment.
    Yang SS; Ma S; Dou H; Liu F; Zhang SY; Jiang C; Xiao M; Huang YX
    Exp Cell Res; 2020 Jun; 391(2):111983. PubMed ID: 32268136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-99a-5p suppresses breast cancer progression and cell-cycle pathway through downregulating CDC25A.
    Qin H; Liu W
    J Cell Physiol; 2019 Apr; 234(4):3526-3537. PubMed ID: 30443946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNA-1298 inhibits the malignant behaviors of breast cancer cells via targeting ADAM9.
    Chen W; Lu Q; Li S; Zhang X; Xue X
    Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33146718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CREPT facilitates colorectal cancer growth through inducing Wnt/β-catenin pathway by enhancing p300-mediated β-catenin acetylation.
    Zhang Y; Wang S; Kang W; Liu C; Dong Y; Ren F; Wang Y; Zhang J; Wang G; To KF; Zhang X; Sung JJ; Chang Z; Yu J
    Oncogene; 2018 Jun; 37(26):3485-3500. PubMed ID: 29563608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-34a Inhibits Breast Cancer Proliferation and Progression by Targeting Wnt1 in Wnt/β-Catenin Signaling Pathway.
    Si W; Li Y; Shao H; Hu R; Wang W; Zhang K; Yang Q
    Am J Med Sci; 2016 Aug; 352(2):191-9. PubMed ID: 27524218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell cycle-related and expression-elevated protein in tumor overexpression is associated with proliferation behaviors and poor prognosis in non-small-cell lung cancer.
    Li W; Zheng G; Xia J; Yang G; Sun J; Wang X; Wen M; Sun Y; Zhang Z; Jin F
    Cancer Sci; 2018 Apr; 109(4):1012-1023. PubMed ID: 29397041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knocking-down of CREPT prohibits the progression of oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc expression.
    Ma J; Ren Y; Zhang L; Kong X; Wang T; Shi Y; Bu R
    PLoS One; 2017; 12(4):e0174309. PubMed ID: 28369091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long Non-Coding RNA TFAP2A-AS1 Inhibits Cell Proliferation and Invasion in Breast Cancer via miR-933/SMAD2.
    Zhou B; Guo H; Tang J
    Med Sci Monit; 2019 Feb; 25():1242-1253. PubMed ID: 30768589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CREPT/RPRD1B promotes tumorigenesis through STAT3-driven gene transcription in a p300-dependent manner.
    Zhai W; Ye X; Wang Y; Feng Y; Wang Y; Lin Y; Ding L; Yang L; Wang X; Kuang Y; Fu X; Eugene Chin Y; Jia B; Zhu B; Ren F; Chang Z
    Br J Cancer; 2021 Apr; 124(8):1437-1448. PubMed ID: 33531691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of microRNA-190 inhibits migration, invasion, epithelial-mesenchymal transition, and angiogenesis through suppression of protein kinase B-extracellular signal-regulated kinase signaling pathway via binding to stanniocalicin 2 in breast cancer.
    Sun G; Liu M; Han H
    J Cell Physiol; 2019 Aug; 234(10):17824-17838. PubMed ID: 30993707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-144 suppresses proliferation, invasion, and migration of breast cancer cells through inhibiting CEP55.
    Yin Y; Cai J; Meng F; Sui C; Jiang Y
    Cancer Biol Ther; 2018 Apr; 19(4):306-315. PubMed ID: 29561704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.